Back to search

Article

Evaluation of Collagen-Derived peptide (EB-203) for Treating Wet Age-Related Macular Degeneration

2026-03-11

Abstract excerpt

<title>Abstract</title> <p>Wet age-related macular degeneration has been one of the challenging ocular diseases due to severe ocular implications like vision loss. As a key protein factor, VEGF has been reported to be closely related with the choroid neovascularization (CNV) as a representative pathogenesis of wet AMD. Conventionally, anti-VEGF antibody therapeutics like aflibercept have been used for improving A...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
155946e1-8698-56c0-8e0b-014afe308c9b
DOI
10.21203/rs.3.rs-7970433/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of Collagen-Derived peptide (EB-203) for Treating Wet Age-Related Macular DegenerationDOI 10.21203/rs.3.rs-7970433/v1
New Generation of Gene Therapies as the Future of Wet AMD TreatmentSemantic proximity
A New Generation of Gene Therapies as the Future of Wet AMD TreatmentSemantic proximity
Engineered RPE Cell Therapy for Controllable Anti-VEGF Delivery in Neovascular AMDSemantic proximity
Preclinical development of a dual targeting bicistronic gene therapy approach for the treatment of wet age-related macular degenerationSemantic proximity
Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration: phase 1 and phase 2 trials in treatment-naïve and anti-VEGF pretreated patientsSemantic proximity
Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse modelSemantic proximity
GB10, a best-in-class antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseasesSemantic proximity
Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular DegenerationSemantic proximity
Eighteen-Month Real-World Outcomes of Intravitreal Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A UK Single- Centre ExperienceSemantic proximity
Repairing the retinal ischemic microenvironment with an engineered exosome-loaded dehydroepiandrosterone peptide hydrogelSemantic proximity
The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspectiveSemantic proximity
In vivo monitoring of active subretinal fibrosis in mice using collagen hybridizing peptidesSemantic proximity
Select a neighboring publication to make it the new centre.